Loading…

Soluble expression of recombinant coagulation factor IX protein using Escherichia coli

Hemophilia B is a congenital bleeding disorder caused by factor IX (FIX) deficiency. Generation of recombinant FIX (rFIX) is required for detecting a Hemophilia B indicator, anti-FIX antibody. In this study, we described a method for producing recombinant FIX (rFIX) using Escherichia coli. We constr...

Full description

Saved in:
Bibliographic Details
Published in:Biochemistry and biophysics reports 2024-07, Vol.38, p.101714-101714, Article 101714
Main Authors: Park, Byoung-Hee, Yun, Hanool, Jeong, Hee-Jin
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hemophilia B is a congenital bleeding disorder caused by factor IX (FIX) deficiency. Generation of recombinant FIX (rFIX) is required for detecting a Hemophilia B indicator, anti-FIX antibody. In this study, we described a method for producing recombinant FIX (rFIX) using Escherichia coli. We constructed a FIX-expressing plasmid without a fusion tag protein-encoding gene and produced rFIX as a soluble form within five days. Dose-dependent curve was obtained from ELISA using anti-FIX antibody, indicating that the rFIX can be used as an antigen to detect anti-FIX antibody with high affinity and sensitivity. •Generation of a recombinant factor IX (rFIX) to compensate for detecting anti-FIX antibody in patients with hemophilia B.•Expression of a soluble form of full-length rFIX with no fusion sequence.•Confirmation of the binding efficiency of rFIX to anti-FIX antibody.
ISSN:2405-5808
2405-5808
DOI:10.1016/j.bbrep.2024.101714